What Medistrava does

Medistrava is an integrated medical solutions partner serving biotech and biopharma companies, operating as a specialty unit within Inizio Medical — itself part of the broader Inizio group comprising more than 11,500 experts across 50 countries. Founded in 2019 and headquartered in London, the company employs 150+ specialists (firmographics report a 251–500 employee range) and delivers services across seven practice areas: medical strategy and excellence, patient engagement, clinical trials optimization, medical analytics and innovation, value and evidence, and corporate and investor communications. The firm serves clients across the drug development lifecycle, from start-up through commercialization, with named customers spanning emerging biotech (Amber Therapeutics, Enara Bio, Quell Therapeutics, Nouscom, Avillion) through to large pharmaceutical companies (Boehringer Ingelheim, AstraZeneca). Disclosed cumulative track record includes IPO mandates on nine markets raising more than $3.5Bn, M&A transactions with total value of approximately $18Bn, partnering transactions exceeding $23Bn, VC financings above $5Bn, and private financings of approximately $2Bn over a 20+ year period.

Name

Medistrava

Legal name

MEDiSTRAVA

Website

https://medistrava.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

251–500 employees

Short description

Medistrava is an Inizio Medical-owned, London-based professional services consultancy providing biotech and pharma companies with integrated medical affairs, clinical trials optimization, patient engagement, value and evidence, and corporate and investor communications services across seven practice areas.

Ownership category

akta.pro rank

Product category

Healthcare Consulting Services

NAICS

Marketing Consulting Services (541613), Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

akta.pro secondary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Medical affairs consulting
• Clinical trial optimization
• Biotech communications
• Patient engagement services
• Pharmaceutical consulting

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Services - Medical Strategy and Excellence: Consulting and strategic services spanning medical affairs transformation, evidence generation strategy, and market access support for biotech and pharma companies.
2. Clinical Trials Optimization Services: End-to-end clinical trial consulting and advisory services covering recruitment planning, quality and risk management, trial diversity, and study start-up.
3. Patient Engagement Services: Patient engagement strategic consultancy, insights gathering, and education/activation services across the drug development lifecycle.
4. Medical Analytics and Innovation: Advanced analytics, digital innovation consulting, and AI-powered solutions for medical affairs and commercial teams.
5. Corporate and Investor Communications: Strategic corporate and financial communications services including IPOs, secondary financings, M&A transactions, partnering transactions, and VC financings.
6. Value and Evidence Services: Pricing and market access strategy, value communications, evidence generation, HEOR and RWE technical expertise along the commercialization pathway.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

MEDiSTRAVA is an integrated medical solutions partner that delivers specialized consulting services to biotech and biopharma companies across the drug development lifecycle. Its core offering spans seven practice areas: Medical Strategy and Excellence, Patient Engagement, Clinical Trials Optimization, Medical Analytics and Innovation (including AI and augmented intelligence), Value and Evidence, and Corporate and Investor Communications. Two flagship technology platforms, iON AI and SITE iMPACT, augment these professional services with AI-powered analytics, content generation, and clinical trial recruitment optimization.

Product overview

MEDiSTRAVA is an integrated medical solutions partner offering a unified platform of specialized services for biotech and biopharma companies. The core offering is organized around seven practice areas: Medical strategy and excellence, Patient engagement (encompassing strategic consultancy, insights and co-creation, education and activation, and Inclusion and Impact), Clinical trials optimization (featuring the flagship SITE iMPACT solution with its three integrated sub-components: SITE iNSIGHTS, SITE eNGAGE, and SITE iNSPIRE), Medical analytics and innovation (including dedicated AI and augmented intelligence services), Value and evidence (with HEOR capabilities), and Corporate and investor communications. The company also offers iON AI as an AI-powered intelligence platform. All services are delivered by over 150 specialists and can be combined into bespoke cross-functional teams to provide scalable solutions from startup through commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• SITE iMPACT Flagship clinical trial recruitment strategy combining data-driven site intelligence, real-time trial insights, mock trials, and proactive site engagement to help sponsors design recruitable studies and reduce rescue scenarios. Built on three integrated sub-components: SITE iNSIGHTS (analytics and data mapping), SITE eNGAGE (comprehensive site engagement strategy), and SITE iNSPIRE (patient and site-facing marketing and education materials).
• iON AI AI-powered intelligence platform built to address the distinct challenges of Medical Affairs, enabling analysis, insight discovery, content generation, and engagement optimization.
• Medical Strategy and Excellence Consulting service designing and delivering customized approaches to accelerate achievement of Medical Affairs goals, including strategic mindset, analytical skills, therapeutic area knowledge, and best practices for solutions that are meaningful, achievable, and measurable.
• Patient Engagement Patient engagement services including strategic consultancy, patient insights and co-creation of solutions, and patient education and activation. Supports delivery of patient-centric strategy, insights, and education across the drug development lifecycle with focus on health literacy and inclusivity.
• Clinical Trials Optimization End-to-end clinical trial support from design through recruitment to real-world implementation, specializing in recruitment planning and rescue, quality and risk management, trial diversity, and study start-up with expertise across multiple therapeutic areas.
• Medical Analytics and Innovation Advanced analytics and digital innovation services including AI and Generative AI capabilities, working at intersection of medical strategy, advanced analytics, and technology to uncover insights that speed time to better strategic decisions.
• Value and Evidence Consulting and technical execution supporting Medical and Access professionals along entire commercialization pathway for drugs, vaccines, devices, diagnostics, and technologies. Includes pricing and market access strategy, value communications, evidence generation, and HEOR/RWE technical expertise.
• Corporate and Investor Communications Strategic corporate and financial communications team working with life sciences companies at all stages of development, supporting fundraising, partnering, profile raising, reputation management, and crisis communications with focus on media, investor, and corporate stakeholders globally.

Quantifiable outcome

• Advisers to over 100 companies over 20+ year period
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fishawack Health: Fishawack Health is a private-equity-backed integrated medical communications and consulting group serving biotech and pharma with medical affairs, scientific communications, and patient engagement offerings — directly comparable to MEDiSTRAVA's integrated services model and customer base.
• Real Chemistry: Real Chemistry (formerly W2O Group) is a data-driven healthcare marketing and communications firm serving biotech and pharma clients with a similar mix of strategic communications, analytics, and AI-enabled services, making it a direct comparable in scale and positioning.
• EVERSANA: EVERSANA is a privately held life sciences commercial services firm providing market access, patient services, HEOR, and medical communications — directly comparable to MEDiSTRAVA's value & evidence, patient engagement, and commercialization support offerings.
• Biolumina: Biolumina is a specialty healthcare advertising agency within Omnicom focused on oncology and specialty biotech launches, providing scientific and creative communications for emerging pharma — closely comparable to MEDiSTRAVA's biotech integrated solutions practice.
• Avalanche Health (formerly Fishawack + close-knit merger): Avalanche Health is the combined entity formed from the merger of Fishawack Group, Dudnyk, and other agencies into a single integrated biopharma commercialization and communications platform — directly comparable to MEDiSTRAVA's integrated biotech commercialization offering.

Broad incumbents

• McCann Health: McCann Health is the global healthcare creative and communications network of IPG, serving large pharma with brand communications, medical affairs, and DTC advertising — overlapping with MEDiSTRAVA's communications work but at much larger scale and broader scope.
• Publicis Health: Publicis Health is the healthcare arm of Publicis Groupe, offering advertising, communications, and consulting to pharma clients worldwide — a broader incumbent competitor that overlaps with MEDiSTRAVA's medical communications and corporate communications offerings.
• Ogilvy Health: Ogilvy Health is WPP's global healthcare communications network, providing medical education, branding, and consulting to pharma clients — a scaled incumbent competitor with overlapping medical affairs and patient engagement capabilities.
• Havas Health & You: Havas Health & You is Havas's integrated global health and wellness network offering creative communications, consulting, and media services to pharma — a broad incumbent with capabilities comparable to MEDiSTRAVA's communications and patient engagement practices.

Others

• Initiate Government Relations: Initiate is a healthcare-focused public affairs and communications agency serving pharma and biotech on policy, government relations, and corporate communications — adjacent to MEDiSTRAVA's corporate and investor communications practice but with a policy focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medistrava